Span Healthcare Private Limited

Shaping India’s healthcare – Vision for the next decade

Shaping India’s healthcare – Vision for the next decade - Medical Buyer India’s healthcare sector is on the verge of significant transformation in the coming years. With a growing population, evolving disease patterns, growing patient needs, advancements in medical technology, and dynamic regulatory frameworks, hospitals and laboratories are gearing up to meet the cha...

Blood donation and transfusion: Expert shares safety tips

Blood donation and transfusion: Expert shares safety tips - Times of India Implementing advanced testing methods like partial phenotype testing ensures the safe transfusion of blood to patients by matching specific red cell a

A study in the journal Advances in Hematology showed pregnant women with sickle cell trait had a greater risk of contracting COVID-19 with more severe symptoms. Vaccinated patients, however, had a 90% lower risk of infection compared with patients who were not vaccinated.
Sickle Cell Trait Can Exacerbate COVID-19 Risk During Pregnancy

Sickle Cell Trait Can Exacerbate COVID-19 Risk During Pregnancy Sickle cell trait (SCT) and pregnancy each exacerbate the symptoms of COVID-19. As a result, pregnant individuals with SCT may have a higher risk of COVID-19 infection.

India on cusp of transformative era in MedTech; Make in India pushes growth

India on cusp of transformative era in MedTech; Make in India pushes growth - Medical Buyer The transformation of India’s healthcare industry has the potential to accelerate tenfold, from $2.7 billion in 2022 to approximately $37 billion by 2030, as per a report by Boston Consulting Group (BCG). However, the over-reliance on imported medical devices, accounting for over 80% of the sector...

Expanding at 35.40% CAGR, India MedTech market to hit USD 124.3B

Expanding at 35.40% CAGR, India MedTech market to hit USD 124.3B - Medical Buyer The India medical devices market is experiencing robust growth, projected to expand at an impressive CAGR of 35.40%, from USD 15 billion in 2021 to approximately USD 124.3 billion by the end of 2028. This growth trajectory is fueled by several key factors including the rising prevalence of health co...

AIIMS Delhi Performs India's First Successful Foetal Blood Transfusion To Save Child With Rare Disorder

AIIMS Delhi Performs India's First Successful Foetal Blood Transfusion To Save Child With Rare Disorder This medical achievement marks the first procedure of its kind in India and only the eighth case reported globally, according to the doctors of All India Institute of Medica

Gaps in govt policy impedes screening of sickle cell disease

Gaps in govt policy impedes screening of sickle cell disease Bengaluru: Absence of a universal antenatal screening policy or central and state guidelines mandating screening for inherited blood disorders like sickle cell disease in Karnataka has led to persistent gaps in prevention efforts.

Addressing Sickle Cell Disease in India: The need for newborn screening

Addressing Sickle Cell Disease in India: The need for newborn screening - Express Healthcare Dr Shuchin Bajaj, Founder and Director, Ujala Cygnus Group of Hospitals

Pre-and post-pandemic landscape of the blood transfusion sector in India

Pre-and post-pandemic landscape of the blood transfusion sector in India Priyanka Barman([email protected]) and Chethan M.World Blood Donor Day 2024 marks a significant milestone as we celebrate 20 years of honouring the se

State joins observance of World Blood Donation Day

State joins observance of World Blood Donation Day : 15th jun24 ~ E-Pao! Headlines State joins observance of World Blood Donation Day - E-Pao! Headlines

Clear national blood policy best way to ensure patients receive safest possible blood: Experts

Clear national blood policy best way to ensure patients receive safest possible blood: Experts HomeHealthClear national blood policy best way to ensure patients receive safest possible... HealthTop Stories Clear national blood policy best way to ensure patients receive safest possible blood: Experts By IANS June 14, 2024 0 57 Share FacebookTwitterPinterestWhatsAppLinkedinTelegramCopy URL New....

Growing at 20% CAGR, Indian medical devices industry to hit USD 50B

Growing at 20% CAGR, Indian medical devices industry to hit USD 50B - Medical Buyer The Indian medical devices industry projected to grow at a Compounded Annual Growth Rate (CAGR) of up to 20% is expected to reach the size of $50 billion by 2030 and $250 billion by 2047, a top industry executive said. “India’s medical device industry, currently valued at $11 billion, is growing...

Jipmer to host month-long blood donation awareness events

Jipmer to host month-long blood donation awareness events Join Jipmer's Department of Transfusion Medicine for a month-long blood donation awareness program starting with a walkathon on June 14.

A study published in the British Journal of Haematology showed experiencing significant or intense symptoms of fatigue was common among most stable patients with sickle cell disease, and several factors including stress, female s*x, acute chest syndrome episodes and poor sleep were independently associated with fatigue. "In view of our present results, we believe that it would be legitimate to address fatigue more systematically in consultations, discuss this issue during patient education programs, and add fatigue as an end-point in therapeutic trials in SCD," researchers wrote.
Significant Fatigue Common in Adult Patients with Sickle Cell Disease

Significant Fatigue Common in Adult Patients with Sickle Cell Disease A lower FACIT-Fatigue score, indicating higher fatigue was independently associated with female s*x, a high BMI, a high stress level, and poor sleep quality.

Growing at 9% CAGR, Indian medical devices market to hit USD 13.4B

Growing at 9% CAGR, Indian medical devices market to hit USD 13.4B - Medical Buyer India medical devices market size was valued at USD 6.2 billion in 2022. The medical devices market industry is projected to grow from USD 6.7 billion in 2023 to USD 13.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.00% during the forecast period (2023 – 2032). Increasing ...

A study in the journal Blood Advances showed young adults with sickle cell disease with six month or longer transitions from pediatric to adult care had higher odds of hospitalization and emergency department visits in their first two years of adult care. "Interventions to prevent gaps in healthcare between pediatric and adult care should be developed and implemented in transition programs," the study team wrote.
Delays in switch to adult sickle cell care tied to more hospitalizations

Gap in switch from pediatric to adult sickle cell care raises... Young adults with SCD with a delay of over six months were twice as likely to be hospitalized than those who switched in under two months.

A study in the journal Antioxidants showed reduced antioxidant status was a frequent experience among patients with transfusion-dependent beta-thalassemia. "Efforts can be done in future to further verify the role of OXY and d-ROMs in TDT pathophysiology, assessing whether they can serve as risk biomarkers and/or targets of interventions aimed to achieve an optimal redox balance, improving quality of life and overall outcomes for patients," researchers wrote.
Antioxidant Depletion Frequent in Patients With Transfusion-Dependent Beta-Thalassemia

Antioxidant Depletion Frequent in Patients With Transfusion-Dependent Beta-Thalassemia Researchers determined patients with transfusion-dependent beta-thalassemia frequently were found to experience antioxidant depletion.

Researchers said they have identified several blood biomarkers linked to fat dysregulation, hemolysis and inflammation that may help predict which patients with sickle cell disease are at risk of acute chest syndrome in the following year. The findings were published in the journal Lipids in Health and Disease.
Biomarkers ID’d to predict acute chest syndrome in sickle cell disease

Biomarkers ID'd to predict sickle cell disease acute chest syndrome Researchers have identified blood biomarkers that could predict a sickle cell disease patient's risk of developing acute chest syndrome.

Recently approved gene therapies for sickle cell disease offer hope for a cure, but the extremely high costs of these treatments and challenges in accessing the necessary care infrastructure hinder their availability to the approximately 8 million individuals globally affected by the condition. The focus on gene editing overlooks more immediate needs for sickle cell patients, such as pain management, highlighting the need for research agendas that prioritize patient experiences and incorporate interdisciplinary collaboration, writes professor of public policy Shobita Parthasarathy.
Innovative Thinking Could Make New Sickle Cell Treatments More Accessible

Innovative Thinking Could Make New Sickle Cell Treatments More Accessible The cost of new gene-based sickle cell treatments isn’t the only barrier to access. Coming up with new ways to treat the whole disease—and person—could make treatment more equitable

Medscape Physician Lifestyle & Happiness Report 2024: The Ongoing Struggle for Balance

Medscape Physician Lifestyle & Happiness Report 2024: The Ongoing Struggle for Balance Doctors reveal how they strive for work-life balance, mental health, and family time in their demanding profession. Their diet, exercise, drinking, and online habits are included.

Blood donation behaviour and strategies to bridge gap for new India

Blood donation behaviour and strategies to bridge gap for new India Taboos and societal norms often impede progress, while poor healthcare and malnutrition are exacerbated by inadequate medical infrastructure at the block and tehsil levels

Centre not to renew licences of blood centers running outside of hospitals

Centre not to renew licences of blood centers running outside of hospitals - Medical Buyer The Central License Approving Authority of the Directorate General of Health Services, Government of India, has issued instructions to all licencing officers to not renew licences of the blood centres running outside of hospitals. Dr Ajay Bagga, Patron of Indian Society of Blood Transfusion (ISBTI),...

Children with sickle cell disease exposed to higher levels of two outdoor air pollutants -- elemental carbon and ground-level ozone -- for 9-14 days were at greater risk of hospitalization, according to a study in the journal Environmental Research. The findings suggest that patients with sickle cell disease "may be sensitive to environmental stressors," researchers wrote.
Short-term air pollution exposure may be tied to child hospitalizations

Short-term air pollution exposure may be tied to child hospital stays Short-term exposure to air pollution may be linked to a higher risk of hospitalization among children with sickle cell disease, per a study.

PM apologises after infected blood scandal cover-up

PM apologises after infected blood scandal cover-up PM truly sorry as inquiry finds authorities covered up scandal and exposed victims to unacceptable risks.

UK infected blood scandal: 30,000 infected with hepatitis C, HIV

UK infected blood scandal: 30,000 infected with hepatitis C, HIV - Medical Buyer The final report from the seven-year inquiry into the UK infected blood scandal has been published today, concluding that patients were knowingly exposed to risks and the medical catastrophe could have been largely, but not entirely, avoided. The British medical scandal resulted in nearly 30,000 peo...